GoFundMAE: Support Glioblastoma Treatment
Donation protected
Glioblastoma killed senators John McCain and Ted Kennedy, and President Biden’s son Beau. That single word whispered by a doctor, “glioblastoma” changes everything. Glioblastoma, a long and complicated word to describe brain cancer. Every year around 12,000 men, women, and children are diagnosed with this specific type of brain cancer. A simple google search will tell you that glioblastoma is “an aggressive type of cancer.” The word itself evokes fear.
There's hope in the form of new treatments. A new treatment option in the form of thermobrachytherapy (TBT). Another long and complicated word to describe a unique device that brings offers a future treatment to those suffering from glioblastoma and breast cancer. That is why the CEO of MAE Group, Janet Kwiatkowski, took on the formidable role of commercializing thermobrachytherapy. An endeavor called “Project Hope”.
Taking the reins from researcher and oncology advocate, Paul Stauffer, Janet promised to get this device to the world through commercialization. While Janet and Paul knew countless lives were impacted through Paul’s academic work, true impact came through getting the device to the masses through commercialization.
In fact, thermobrachytherapy, a device that significantly increases 5-year survival rates for patients, has been around for decades. DECADES.
As Janet states, “Commercialization and markets seem to be cold and calculating words. However, there is another side to those words; commercialization brings this life-saving product to global markets providing hope and courage for people diagnosed with devastating diseases. The courage to fight and believe they can win or at least beat the odds is crucial to standing up to the toughest fight they will ever have to face with their family.”
As such, every step we take and every decision we make moves towards the commercialization of the TBT system, as a platform oncology-based technology.
With grit and determination, Janet and her team at MAE Group are putting their money and their time behind this device, for hope. Project Hope. MAE Group is now transitioning into the design and development with ultimate treatment as the goal.
As we go through the process of receiving funding, we need a few essential items to continue. These items include prototype equipment such as an additive manufacturing 3-D printer, high resolution infrared camera, engineering application software, and design and prototype test equipment such as tensile, burst, fatigue machines. The purchase of the essential equipment and software will enable MAE Group and their advisory team to continue the development of this critical technology as we seek additional investment funding needed for clinical studies and ultimate commercialization.
If you would like to bring hope to patients, families, and countless others, please contribute to Project Hope.
#GoMAEforGray
#GoFundMe
#glioblastoma
#GBM
#BrainCancerAwareness
#GoGray
There's hope in the form of new treatments. A new treatment option in the form of thermobrachytherapy (TBT). Another long and complicated word to describe a unique device that brings offers a future treatment to those suffering from glioblastoma and breast cancer. That is why the CEO of MAE Group, Janet Kwiatkowski, took on the formidable role of commercializing thermobrachytherapy. An endeavor called “Project Hope”.
Taking the reins from researcher and oncology advocate, Paul Stauffer, Janet promised to get this device to the world through commercialization. While Janet and Paul knew countless lives were impacted through Paul’s academic work, true impact came through getting the device to the masses through commercialization.
In fact, thermobrachytherapy, a device that significantly increases 5-year survival rates for patients, has been around for decades. DECADES.
As Janet states, “Commercialization and markets seem to be cold and calculating words. However, there is another side to those words; commercialization brings this life-saving product to global markets providing hope and courage for people diagnosed with devastating diseases. The courage to fight and believe they can win or at least beat the odds is crucial to standing up to the toughest fight they will ever have to face with their family.”
As such, every step we take and every decision we make moves towards the commercialization of the TBT system, as a platform oncology-based technology.
With grit and determination, Janet and her team at MAE Group are putting their money and their time behind this device, for hope. Project Hope. MAE Group is now transitioning into the design and development with ultimate treatment as the goal.
As we go through the process of receiving funding, we need a few essential items to continue. These items include prototype equipment such as an additive manufacturing 3-D printer, high resolution infrared camera, engineering application software, and design and prototype test equipment such as tensile, burst, fatigue machines. The purchase of the essential equipment and software will enable MAE Group and their advisory team to continue the development of this critical technology as we seek additional investment funding needed for clinical studies and ultimate commercialization.
If you would like to bring hope to patients, families, and countless others, please contribute to Project Hope.
#GoMAEforGray
#GoFundMe
#glioblastoma
#GBM
#BrainCancerAwareness
#GoGray
Organizer
MAE Group
Organizer
Deerfield, NH
